GU Cancers 2019 | Real-world implications of the ACES study

Prantik Das

Prantik Das, MBBS, MRCP, FRCR, of the Lincoln County Hospital, Lincoln, UK, speaks at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA. Dr Prantik describes the methods and results of the real-world ACES study (NCT03360721), highlighting the implications of the findings. The ACES study investigated abiraterone acetate plus prednisone/prednisolone compared with enzalutamide in metastatic castration resistant prostate cancer before or after chemotherapy.

Share this video